Pharmaceutical & life sciences

Pharmaceutical Artwork Management: Systems, Regulatory Artwork Services or Hybrid

Choosing how to control labels, leaflets, cartons and IFUs across products, markets and contract manufacturers? Compare software, outsourced regulatory artwork services and hybrid models, see what evidence to request, then tell us your requirements and we will match you with providers that appear to fit.

Get matched for pharma artworkFree for buyers · about 1 minute · no obligation
Artwork types
Labels, PILs, IFUs, cartons, components
Decision
System, outsourced service or hybrid
Must evidence
Change control, audit trail, approvals
Cost to buyers
Free, no obligation

What is pharmaceutical artwork management?

Pharmaceutical artwork management is the controlled process of turning approved regulatory text into print-ready labels, patient information leaflets, cartons, IFUs and other packaging components, and proving that every version released matches what was approved. Changes come from variations, safety updates, new markets, site or CMO transfers and supplier changes, and each one has to reach every affected component.

Buyers usually choose between three routes: an artwork management system (software your team runs), regulatory artwork services (an external team that produces and checks artwork for you), or a hybrid in which an external team works inside a governed system. The right choice depends on volume, internal capacity, how many CMOs and markets you manage, and what your quality system requires.

We do not assume any system is validated or any provider is suitable for GxP-relevant work. We qualify those requirements with you before suggesting anyone, and you should verify every claim yourself.

Artwork management system for pharmaceuticals: when software fits

An artwork management system suits organisations with in-house artwork or packaging staff who need one controlled workflow: change requests, source-text control, routed reviews, electronic approval, version comparison and an audit trail for every component.

It shifts the problem from capacity to control. If your bottleneck is that nobody has time to produce the artwork, software alone will not fix it.

  • Good fit: steady change volume, internal artwork team, need for a single audit record
  • Check: electronic signature controls, role permissions, audit trail export, hosting and data residency
  • Check: whether the vendor supplies validation documentation and supports your own computer system validation approach

Regulatory artwork services: when outsourcing fits

Regulatory artwork services (sometimes called managed or outsourced pharmaceutical artwork) provide trained artworkers and proofreaders who produce, check and revise components for you, usually against your SOPs and approval process.

This suits teams facing backlogs, launches, portfolio acquisitions or variation waves that exceed in-house capacity. Ask how the provider controls source text, trains staff on your conventions and records each check.

  • Good fit: capacity shortfall, peaks in variation work, limited internal artwork staff
  • Check: proofreading method (manual and automated), documented checks, turnaround commitments, confidentiality
  • Check: whose system the work is recorded in, and how you retain the approval record

Hybrid: an external team inside a governed system

Many high-volume pharmaceutical organisations combine both: a provider produces artwork, and every job, review and approval is recorded in a system the client controls or can audit. This keeps capacity flexible without losing the evidence trail.

If you are unsure which model fits, that is exactly what the requirements assessment is for.

Validation evidence buyers should request

Ask for documents, not assurances. Whether a system or service is appropriate is your organisation's decision.

  • Validation or qualification documentation the vendor supplies, and what remains your responsibility
  • How electronic records and signatures are controlled, and how the audit trail is protected and reviewed
  • Release and change management for the software itself: how updates are communicated and tested
  • Supplier audit support: will they host or answer a supplier audit or questionnaire?
  • Data hosting location, backup, retention and exit arrangements
  • For services: SOPs, training records approach and documented proofreading checks

Working across multiple CMOs and packaging sites

When several contract manufacturers and packaging sites print your components, the risks multiply: different templates, dielines, barcode and code conventions, and approval contacts. Ask how a system or provider manages external reviewers, site-specific technical specifications and handover of approved files to each CMO.

  • External reviewer access without sharing your whole library
  • Site-specific dielines and technical drawings linked to each component
  • Clear record of which approved version was released to which site

Source-text change control, country variants and audit trails

  • Approved source text (for example from the regulatory record) held as the single reference, with changes tracked
  • Where-used visibility: every carton, label and leaflet affected by a text change
  • Country and language variants managed against a master, with translations reviewed
  • Automated text and graphic comparison between versions and against source
  • An audit trail per component: who changed, reviewed and approved what, and when

Integrations: RIM, QMS, ERP and SharePoint

Artwork rarely stands alone. Ask which integrations exist today (not on a roadmap) with regulatory information management (RIM), quality management (QMS) change control, ERP material masters and document stores such as SharePoint, and whether they are standard connectors or custom projects.

Who is responsible for what: software, services and your team

Artwork management software is a procurement decision: a platform that routes labels, leaflets and cartons for review, keeps every version, records who approved what and when, and hands final files to suppliers. It does not design artwork or make regulatory judgements.

Artwork services and workflow consultants are a different purchase: people who produce artwork, run proofreading or redesign your approval process. Some providers offer both, so ask which parts of their proposal are software and which are people.

Whichever you choose, legal and regulatory sign-off stays with your organisation (for medicines, the licence holder). Ask providers to show how their approval records, version history and audit trail support your reviewers, not replace them.

Implementation in a regulated environment: what to plan for

Regulated rollouts commonly take longer than unregulated ones because evidence must be produced and reviewed at each stage. These are indicative ranges, not quotes. Real timelines depend on scope, validation needs, integrations, data migration and how quickly your own reviewers can take part.

  • Requirements and risk assessment, including which records are GxP-relevant.
  • Supplier assessment of the provider, proportionate to risk and your quality procedures.
  • Configuration and verification against your requirements, with documented evidence.
  • Migration of live, approved artwork and source text only, with reconciliation.
  • Training, SOP updates and a controlled go-live, often product family by product family.

Common mistakes in pharmaceutical artwork projects

  • Treating the artwork system as the source of approved text instead of linking it to the controlled source.
  • Not defining which country variants share master content and which diverge.
  • Allowing CMOs to work from emailed files outside the controlled workflow.
  • Accepting a provider's validation pack as a substitute for your own assessment.
  • Planning go-live during a peak of variations or launches.

Related guides: the artwork approval process

Who this is for

  • Pharmaceutical manufacturers and marketing authorisation holders
  • Generic and consumer healthcare companies with large portfolios
  • Medical device and diagnostics manufacturers managing IFUs and labels
  • Contract manufacturers and packagers handling client artwork

Common pain points

  • Regulatory changes that must reach many components and markets by a deadline
  • Leaflet and label text that must match approved source documents exactly
  • Several CMOs and packaging sites with different specifications
  • Approval records spread across email, PDFs and shared drives
  • In-house artwork capacity that cannot absorb variation peaks

How a controlled pharmaceutical artwork change typically runs

  1. 01

    Change request

    A regulatory, safety or supply change is raised and assessed for impact.

  2. 02

    Source text

    Approved text is confirmed and every affected component identified.

  3. 03

    Artwork and checks

    Components are updated and compared against source and previous versions.

  4. 04

    Review and approval

    Regulatory, QA and other reviewers approve; the record is retained per version.

  5. 05

    Release to sites

    Approved files are released to each CMO or packaging site with traceability.

Vendor evaluation checklist

Use this to compare systems, services or hybrid offers on the same terms.

Source-text control
How approved text is held, changed and compared.
Where-used
Can it show every component affected by one change?
Approvals
Role-based routes, electronic sign-off and rejection reasons.
Audit trail
Complete, protected, exportable record per version.
Comparison
Automated text and graphic comparison against source.
Variants
Country and language versions managed against a master.
External parties
CMO, printer and agency access with controlled permissions.
Validation support
Documentation supplied and responsibilities defined.
Integrations
RIM, QMS, ERP, SharePoint: existing, not roadmap.
Capacity
For services: team size, peak handling and turnaround.

System, regulatory artwork service or hybrid?

Artwork management systemRegulatory artwork serviceHybrid
SolvesControl and evidenceCapacity and expertiseBoth
Your teamProduces and approvesApprovesApproves; may produce some
Approval record heldIn your systemDepends on providerIn a governed system
Best whenSteady volume, in-house staffBacklogs, launches, peaksHigh volume, many CMOs
Key checkValidation documentationSOPs and documented checksWho owns the record

How to choose

  • Start with constraints: capacity, number of CMOs, markets and components per change
  • Decide who must own the approval record
  • Ask every option for the same evidence using the checklist above
  • Run a pilot on a real, representative change before committing

Questions to ask vendors and providers

  • Which pharmaceutical organisations of similar scale use this today, and can we speak to one?
  • What validation documentation do you provide, and what is our responsibility?
  • How do you handle multiple CMOs and external reviewers?
  • Which RIM, QMS and ERP integrations are live today?
  • How is source text controlled and compared?

Typical pharmaceutical scenarios

Safety update across markets

One text change affecting leaflets and cartons in many countries.

CMO or site transfer

Re-issuing components to a new site's specifications with full traceability.

Portfolio acquisition

Bringing acquired products into your artwork process and conventions.

Launch peak

Extra capacity for a launch without lowering checking standards.

Implementation considerations

Plan for migrating approved artwork and source text, defining roles and approval routes, and agreeing what validation work your quality team requires. For services, agree SOPs, checking standards and how the record is returned to you.

Timelines vary widely by scope, integrations and validation approach; be wary of any fixed promise made before requirements are understood.

Frequently asked questions

What is the difference between an artwork management system and regulatory artwork services?

A system is software your team uses to control and evidence artwork changes. Regulatory artwork services provide people who produce and check the artwork for you. A hybrid combines an external team with a governed system.

Is any artwork management system 'validated' out of the box?

Validation applies to how a system is used in your environment. Vendors may supply documentation that supports it, but whether a system is appropriate for your quality system is your organisation's decision. We do not claim any provider is validated.

Can you match us with providers for multi-CMO, multi-market work?

Yes, that is a common requirement. Tell us your components, markets, sites and preferred model in the assessment and we will review which providers appear relevant before contacting you.

Do you charge pharmaceutical companies for matching?

No. The service is free for buyers. We may receive fees from providers for successful introductions, as explained in our commercial disclosure.

Do you give regulatory advice?

No. Regulatory requirements should be confirmed by qualified specialists. We help you compare solution types and providers.

Should artwork changes be triggered from regulatory systems?

Many organisations want change requests to start from an approved regulatory or quality change so that every affected component is identified. Whether that is practical depends on your systems and integration options, so ask providers to demonstrate it with your scenario.

Official guidance (external)

Requirements assessment

Get matched for pharmaceutical artwork management

Tell us your components, markets, CMOs and preferred model. A person reviews it before we suggest any provider, and nothing is shared without contacting you first.